Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Showing 1 to 10 of 10

TitleReference numberPublishedLast updated
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Liposuction for chronic lymphoedemaHTG622
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Intramedullary distraction for upper limb lengtheningHTG621
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783

Results per page

  1. 10
  2. 25
  3. 50
  4. All